World Health Organization (WHO)
"Health is a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity" (WHO constitution).
IASP is a Nongovernmental Organization (NGO) Affiliate of the World Health Organization (WHO).
WHO Access and Control Newsletter
This newsletter will update you on both issues of drug control as well as access to controlled medicines, especially if the World Health Organization is involved. Generally speaking, these issues will be any matter related to the evaluation of substances within the framework of the UN drug conventions, especially the 1961 and 1971 Conventions, and any matter related to WHO's Access to Controlled Medications Programme (ACMP). The newsletter will be published at irregular intervals.
WHO Policy Guidelines
Guide on Estimating Requirements for Substances under International Control
The World Health Organization (WHO), the International Narcotics Control Board (INCB), and global experts joined forces to develop a new tool to assist countries to estimate their annual requirements for narcotic drugs for medical purposes. An important treaty requirement of the Single Convention on Narcotic Drugs is that National Competent Authorities (NCA) shall submit these estimates annually to the INCB in order to ensure that the amounts of available narcotic drugs and other psychoactive substances are limited to quantities required for medical and scientific purposes.
However, some countries do not submit these reports, or some submit estimates that are very low with no chance of meeting the medical need in their country that can be supported by their existing healthcare infrastructure. Lack of report or incorrect report can serve as one of many barriers to patient access to these medications by slowing or preventing exports of the medications into the country.
Therefore, in order to allow for increased consumption of these medications, the WHO and INCB convened a working group that drafted a new document called “Guide on Estimating Requirements for Substances under International Control.” Intended to assist NCAs in calculating the estimated requirements for controlled substances, the Guide identifies different methods, explains their potential strengths and weaknesses, and provides an overview of the major issues that need to be considered in order to apply these methods accurately.
Ensuring Balance in National Policies on Controlled Substances, Guidance for Availability and Accessibility for Controlled Medicines
The WHO Policy Guidelines for Controlled Substances provide guidance on policies and legislation with regards to availability, accessibility, affordability and control of medicines made from substances regulated under the international drug control conventions, herein referred to as "controlled medicines". Their scope encompasses "all controlled medicines", but with a specific focus on essential medicines.
This book elaborates on the background and then provides 21 guidelines on various topics: content of drug control legislation and policy; authorities and their role in the system; policy planning for availability and accessibility; healthcare professionals; estimates and statistics; procurement; and nationally listed drugs. Each guideline has an elucidation and a description of the legal context. The Country Assessment Checklist enables the user to determine which guidelines still need to be worked on.
WHO Publications Written in Collaboration with IASP
Neurological Disorders: Public Health Challenges. 2006, ISBN-13 978-9-241563-36-9, 229 pages. Available for purchase at the WHO Bookstore.
Cancer Pain Relief and Palliative Care in Children (Available in English, French and Spanish). 1998, ISBN-13 978-9-241545-12-9, 85 pages. Available for purchase at the WHO Bookstore.
World Health Day
WHO Collaborating Centers
Regional Offices of WHO:
Important Links within WHO